User talk:Danah.Albreiki

From EyeWiki

Assigned editor status

 Article statusDate reviewed
AkinetopsiaUpdate Pending3 March 2023
Balint SyndromeUpdate Pending3 March 2023
Calcitonin Gene-Related Peptide (CGRP) Antibodies in Neuro OphthalmologyUpdate Pending3 March 2023
Cerebral Polyopia (Cerebral Diplopia)Update Pending3 March 2023
Cerebral Visual ImpairmentUp to Date1 August 2023
Junctional Scotoma and Junctional Scotoma of TraquairUpdate Pending3 March 2023
Monocular Occipital Temporal Crescent SyndromeUpdate Pending4 March 2023
Multiple SclerosisUpdate Pending26 May 2020
Neuro-ophthalmic Findings in ComaUp to Date20 September 2023
Neuro-ophthalmic Manifestations in Adults after Childhood Periventricular LeukomalaciaUpdate Pending6 March 2023
Neuro-ophthalmic manifestations of Polyarteritis NodosaUp to Date21 September 2023
Neuropathy, Ataxia, Retinitis Pigmentosa (NARP) SyndromeUp to Date21 September 2023
Ocular Features of CraniopharyngiomaUp to Date24 September 2023
Ocular Manifestations of Polyneuropathy, Organomegaly, Endocrinopathy, Myeloma Protein, and Skin Changes (POEMS) SyndromeUpdate Pending16 November 2020
Ocular Manifestations of Subclavian Steal SyndromeUpdate Pending15 May 2020
Ocular TorticollisUp to Date14 September 2023
Oculogyric CrisisUpdate Pending4 March 2023
Oculomotor ApraxiaUpdate Pending12 January 2020
Ophthalmologic Manifestations in MELASUpdate Pending5 October 2020
Optic PitsUp to Date25 July 2023
Orbital MassesUpdate Pending6 February 2023
PapilledemaUpdate Pending23 April 2021
Postoperative Decompensated Strabismus Following Otherwise Uncomplicated Ocular SurgeriesUpdate Pending22 April 2022
Stellate Ganglion Block Use for Ocular ConditionsUpdate Pending31 August 2021
Stereopsis and Tests for StereopsisUpdate Pending2 April 2018
Tadpole PupilUpdate Pending20 November 2019
Tocilizumab for Management of Graves OrbitopathyUp to Date2 April 2023
Vici SyndromeUp to Date8 May 2023

Portal page

The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.